Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-016069
Filing Date
2025-09-29
Accepted
2025-09-29 17:29:50
Documents
79
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 3181016
2 EX-31.1 ex31-1.htm EX-31.1 12856
3 EX-31.2 ex31-2.htm EX-31.2 13233
4 EX-32.1 ex32-1.htm EX-32.1 6258
5 EX-32.2 ex32-2.htm EX-32.2 6531
6 GRAPHIC audit_001.jpg GRAPHIC 30462
  Complete submission text file 0001493152-25-016069.txt   14405390

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ppcb-20250630.xsd EX-101.SCH 74094
8 XBRL CALCULATION FILE ppcb-20250630_cal.xml EX-101.CAL 85537
9 XBRL DEFINITION FILE ppcb-20250630_def.xml EX-101.DEF 400346
10 XBRL LABEL FILE ppcb-20250630_lab.xml EX-101.LAB 685152
11 XBRL PRESENTATION FILE ppcb-20250630_pre.xml EX-101.PRE 565724
81 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2056750
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-42806 | Film No.: 251357479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)